Personal Wealth Partners’s AbbVie ABBV Stock Holding History

Personal Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,395	Closed	-$388K	–	3
2022 Q1	$388K	Hold	2,395	–	–	0.17%	54
2021 Q4	$324K	Hold	2,395	–	–	0.13%	62
2021 Q3	$258K	Hold	2,395	–	–	0.11%	65
2021 Q2	$270K	Buy	2,395 +29	+1%	+$3.27K	0.11%	65
2021 Q1	$256K	Hold	2,366	–	–	0.12%	64
2020 Q4	$254K	Sell	2,366 -128	-5%	-$12.3K	0.12%	59
2020 Q3	$218K	Buy	2,494 +128	+5%	+$12.1K	0.11%	65
2020 Q2	$232K	Buy	+2,366	New	+$208K	0.13%	56
2020 Q1	–	Sell	-2,388	Closed	-$211K	–	64
2019 Q4	$211K	Hold	2,388	–	–	0.09%	65
2019 Q3	$181K	Buy	2,388 +1,026	+75%	+$70.3K	0.08%	71
2019 Q2	$99K	Buy	+1,362	New	+$107K	0.05%	89

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Personal Wealth Partners's ABBV Position: Q2 2022 in Review

Personal Wealth Partners sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 2,395 shares — an estimated $388K sold.

Personal Wealth Partners first reported a position in ABBV in Q2 2019 and held it in 11 quarters. The position peaked at $388K in Q1 2022. 3,004 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

Personal Wealth Partners reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
Personal Wealth Partners sold 2,395 AbbVie shares in Q2 2022, an estimated $388K.
Personal Wealth Partners first reported a position in AbbVie in Q2 2019 and held it in 11 quarters.
Personal Wealth Partners's AbbVie position peaked at $388K in Q1 2022.
3,004 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Personal Wealth Partners's 13F filing for Q2 2022.